Tradestie Institutional Equity Comparison Engine
FEMY vs KMTS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KMTS Overall Edge
KMTS Captures Institutional Edge (1โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kestra Medical Technologies, Ltd. Common Stock (KMTS) driven by superior Growth & Margin while FEMY counters with relative strength in Momentum & Technical. Fundamentally, FEMY trades at N/M Forward P/E with -763.9% operating margin (-18.9% YoY revenue) versus KMTS at N/M Forward P/E and -134.5% operating margin (+59.9% YoY). In options structure, FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KMTS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
FEMY N/M vs KMTS N/M Fwd P/E
Growth & Margin Winner
KMTS
Op Margin -763.9% vs -134.5% ยท YoY -18.9% vs +59.9%
Momentum & Technical Winner
FEMY
1Y +54.8% vs +12.3% ยท 52W Pos 17% vs 73%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
FEMY
NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap
$11.9M
1M Return
-22.42%
1Y Return
+54.78%
Forward P/E
N/M
Unified AI Score
52.6 / 100
HOLD
Tech 61.0
Fund 62.0
Flow 50.0
Mom 64.0
KMTS
NASDAQ
Kestra Medical Technologies, Ltd. Common Stock
Surgical & Medical Instruments & Apparatus
$27.97
-2.34% 1D
Market Cap
$1.7B
1M Return
+2.68%
1Y Return
+12.28%
Forward P/E
N/M
Unified AI Score
43.8 / 100
HOLD
Tech 21.0
Fund 39.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FEMY +54.78%
KMTS +12.28%
Spread: +42.5 pp (FEMY Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | FEMY Revenue | KMTS Revenue | FEMY Op. Margin | KMTS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | $0M | N/A | -668.0% | N/A | FEMY |
| FY2021 | $0M | N/A | -706.7% | N/A | FEMY |
| FY2022 | $0M | N/A | -961.7% | N/A | FEMY |
| FY2023 | $0M | N/A | -1353.4% | N/A | FEMY |
| FY2024 | $0M | $30M | -1091.8% | -305.8% | KMTS |
| FY2025 | $0M | $60M | -767.0% | -177.8% | KMTS |
| FY2026 | N/A | $100M | N/A | -141.6% | KMTS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FEMY | KMTS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $11.9M | $1.7B | Larger Scale | KMTS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -18.9% | +59.9% | Higher Growth | KMTS |
| Operating Margin (TTM) Profitability | -763.9% | -134.5% | Higher Margin | KMTS |
| Net Profit Margin Profitability | 0.0% | -140.4% | Higher Margin | FEMY |
| Return on Equity (ROE) Capital Efficiency | -425.0% | -73.7% | Higher ROE | KMTS |
| 52-Week Range Position Momentum | 17% ($0โ$6) | 73% ($17โ$32) | Stronger Trend | KMTS |
| Beta / 30D Volatility Risk Regime | 4.01ฮฒ ยท 72% Vol | 1.84ฮฒ ยท 63% Vol | Lower Realized Risk | KMTS |
| Unified Institutional Score Composite Signal | 52.6 / 100 (HOLD) | 43.8 / 100 (HOLD) | Higher Composite | FEMY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FEMY vs KMTS Buy Guide
FEMY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
KMTS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FEMY nor KMTS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.